Rotavirus vaccine product switch in Ghana: An assessment of service delivery costs, switching costs, and cost-effectiveness.

• Main Authors: Richmond Owusu (Author), Mercy Mvundura (Author), Justice Nonvignon (Author), George Armah (Author), John Bawa (Author), Kwadwo Odei Antwi-Agyei (Author), Kwame Amponsa-Achiano (Author), Frederick Dadzie (Author), George Bonsu (Author), Andrew Clark (Author), Clint Pecenka (Author), Frederic Debellut (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ghana introduced rotavirus vaccine (ROTARIX 1-dose presentation) into the routine national immunization program in 2012 and switched to a different product (ROTAVAC 5-dose presentation) in 2020. ROTAVAC has a lower price per dose (US$0.85 versus US$2.15 for ROTARIX) and smaller cold chain footprint...